If you have overwhelming data, firstly on safety then on performance our take out partner being one of the top 2 ,, with their resources could expedite Phase III ... BOT have been smart with large participant numbers,, the data on that size of participants is what the FDA analyse.
BOT have taken the hard road , prescription meds make a scientific claim unlike OTC lotions and potions.... no claim, no foul..
The value chain of script is phenomenal plus it will differentiate BOT from the wannabes ,,, Think of BOT as Coke and all others as imitation Cola
Bot Chart, page-323
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.008(2.38%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $624.4K | 1.958M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 440962 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 515755 | 15 |
View Market Depth
| Last trade - 13.40pm 22/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
